These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2161716)

  • 21. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.
    Mihara H; Lee S; Shimohigashi Y; Aoyagi H; Kato T; Izumiya N; Costa T
    Biochem Biophys Res Commun; 1986 May; 136(3):1170-6. PubMed ID: 3013169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
    Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
    Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord.
    Stevens CW; Lacey CB; Miller KE; Elde RP; Seybold VS
    Brain Res; 1991 May; 550(1):77-85. PubMed ID: 1653636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic localization of opiate kappa-receptors in the guinea-pig brain.
    Foote RW; Maurer R
    Eur J Pharmacol; 1982 Nov; 85(1):99-103. PubMed ID: 6295776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of opioid binding subtypes in the bovine adrenal medulla.
    Bunn SJ; Marley PD; Livett BG
    Neuroscience; 1988 Dec; 27(3):1081-94. PubMed ID: 2855262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny and distribution of opioid receptors in the rat brainstem.
    Xia Y; Haddad GG
    Brain Res; 1991 May; 549(2):181-93. PubMed ID: 1653081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective effects of ethanol on opiate receptor subtypes in brain.
    Khatami S; Hoffman PL; Shibuya T; Salafsky B
    Neuropharmacology; 1987 Oct; 26(10):1503-7. PubMed ID: 2825059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.